At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution may contribute to the development of more effective management options that are tailored to individual genetic profiles – this is termed ‘precision medicine’.
ESMO 2014: Tumour evolution and precision medicine
20th March 2015
Oncology
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now